Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, BZstocks, DDStocks, HighYieldStocks, Mykkus, SK510
Search This Board: 
Last Post: 2/23/2018 8:18:07 PM - Followers: 451 - Board type: Free - Posts Today: 196



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold

Important ARYC video, take a look



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#68420  Sticky Note UPDATED - ARYC Potential revenue streams partial list: BZstocks 02/20/18 06:13:34 PM
#67208  Sticky Note Silicon Valley Biotech Arrayit (ARYC) is located in SK510 02/07/18 05:39:06 PM
#66938  Sticky Note For those who are new to Arrayit Corporation, HighYieldStocks 02/06/18 09:21:39 AM
#66927  Sticky Note New investors in Silicon Valley biotech (trading at UndervaluedStocks 02/06/18 12:33:01 AM
#66899  Sticky Note New investors: Please take a moment to review DDStocks 02/05/18 06:05:23 PM
#66897  Sticky Note IMPORTANT: To all who are new to the techmover 02/05/18 05:59:59 PM
#69282   Can a stock chart look any nicer than Arrayit? UndervaluedStocks 02/23/18 08:18:06 PM
#69281   Lol you got that right real easy to see! DDStocks 02/23/18 08:07:45 PM
#69280   That’s exactly what I’m seeing here also. It’s JH Mcdough 02/23/18 07:40:45 PM
#69279   Getting pretty easy to spot who it is Godsnunba1 02/23/18 07:40:28 PM
#69278   That is what I'm hoping for (Maximum effect). 0cash 02/23/18 07:20:03 PM
#69277   I'm hoping '14 and '15 fins are released Play4keeps2 02/23/18 07:12:38 PM
#69276   Wow, BZ, that's a great map! It Play4keeps2 02/23/18 07:04:51 PM
#69275   Worldwide sales: BZstocks 02/23/18 07:00:56 PM
#69274   How much resistance will we have at .02 BZstocks 02/23/18 06:58:18 PM
#69273   weekly- doesn't get much better than this. BZstocks 02/23/18 06:53:48 PM
#69272 BZstocks 02/23/18 06:52:14 PM
#69271   what? The_Free_Nebula 02/23/18 06:30:12 PM
#69270   And the Bid was at .017. When your UndervaluedStocks 02/23/18 06:29:03 PM
#69269   I can’t wait until next week! I hope Penny Traders Club 02/23/18 06:14:48 PM
#69268   The bid Is really where the market is...When The_Free_Nebula 02/23/18 06:11:36 PM
#69267   $ARYC Overall Average:100% BUY Overall Average Signal calculated from Ace508 02/23/18 06:00:28 PM
#69266   Ummm, looks like someone tried to take out Jeffpacman 02/23/18 05:58:01 PM
#69265   This is great DD. New investors should definitely Ace508 02/23/18 05:57:23 PM
#69264   Funny how that works. Negativity can't bring this SK510 02/23/18 05:54:40 PM
#69263   Steady growth each week is exactly what this SK510 02/23/18 05:53:32 PM
#69262   Yeah if we hit that point we'll end SK510 02/23/18 05:53:12 PM
#69261   I think sooner personally DDStocks 02/23/18 05:45:22 PM
#69260   Agreed! gaining weekly DDStocks 02/23/18 05:44:31 PM
#69259   Absolutely UndervaluedStocks 02/23/18 05:43:28 PM
#69258   Ya think in the next 30 days we'll Play4keeps2 02/23/18 05:43:08 PM
#69257   ........and they’re coming UndervaluedStocks 02/23/18 05:41:29 PM
#69256   The negative post the higher the pps goes :-D Penny Traders Club 02/23/18 05:39:26 PM
#69255   Nice ask slaps end of day :) Ace508 02/23/18 05:31:14 PM
#69254   It’s up 11.18% today. Someone tried to paint Ace508 02/23/18 05:29:33 PM
#69253   Are we Green my TD says -11.25% 0cash 02/23/18 05:19:14 PM
#69252   Probably one of our resident non believers. However Doc Hollywood 02/23/18 05:13:33 PM
#69251   If this crosses .02 without the audits published r2g2 02/23/18 04:58:26 PM
#69250   Yes sir. Great week SK510 02/23/18 04:56:26 PM
#69249   Happens a lot on this one... SK510 02/23/18 04:56:03 PM
#69248   Very elusive but should be well worth the wait SK510 02/23/18 04:55:41 PM
#69247   ARYC - can't argue green. The only The_Free_Nebula 02/23/18 04:36:23 PM
#69246   Or who tired to tank it to .0135 DDStocks 02/23/18 04:07:53 PM
#69245   Absolutely! Love it when there’s negative posts and Mykkus 02/23/18 04:04:42 PM
#69244   Blah blah blah. Just keep buying UndervaluedStocks 02/23/18 04:04:31 PM
#69243   Great close- continued strength and momentum! BZstocks 02/23/18 04:04:24 PM
#69242   Nice close! More peeps committing their cash as Doc Hollywood 02/23/18 04:03:58 PM
#69241   Nice close! Penny Traders Club 02/23/18 04:03:40 PM
#69240   Another solid day at ARYC. I wonder who the UndervaluedStocks 02/23/18 04:03:36 PM
#69239   ARYC My only winner this year. BS, ohiotom 02/23/18 03:51:53 PM
#69238   They want to push this up, not down... Jeffpacman 02/23/18 03:33:16 PM
#69237   Being that the company is on the west Doc Hollywood 02/23/18 03:23:00 PM
#69236   After hours news? UndervaluedStocks 02/23/18 03:20:06 PM
#69235   I'd LMAO if someone took out the .016 Jeffpacman 02/23/18 03:15:39 PM
#69234   fir ARYC to lock in progress bid has The_Free_Nebula 02/23/18 03:09:49 PM
#69233   Like I said yesterday The_Free_Nebula 02/23/18 03:05:05 PM